Alzheimer Disease Clinical Trial
Official title:
Partners in Dementia Care
Background: Partners in Dementia Care (PDC) is a care coordination and support service
intervention for veterans with dementia and their family caregivers, delivered through
partnerships between VA medical centers and local Alzheimer's Association Chapters. PDC was
created from seven years of research and development, and was designed to be a feasible and
practical intervention to integrate health, community, and support services. PDC has a
standardized protocol for care coordination and support services, including guidelines for
care plan assessment, care plan development and implementation, ongoing monitoring, and
reassessment. It also offers a structured training curriculum for providers and an
operations manual for uniform implementation.
Objectives: The primary objective of this investigation is to rigorously test the impact of
PDC on a number of outcomes for veterans with dementia, family caregivers, and health care
providers. Within VA Medical Centers, the focus will be on improving dementia care in
primary care clinics, including geriatrics. Two specific research objectives and
corresponding hypotheses will be addressed: 1. To test the impact of PDC on three categories
of outcomes: psychosocial well-being outcomes (patient and caregiver effects); health care
service use (patient effects only); and health care cost (patient effects only). HI:PDC,
compared to usual care, will improve psychosocial well-being, including depression, health
status, adequacy of care, and quality of care for patients with dementia and their
caregivers. H2:PDC, compared to usual care, will reduce health care service use for patients
with dementia, including hospital admissions, emergency department visits, nursing home
admissions, and physician visits. H3:PDC is preferred to usual care based on
cost-effectiveness and cost-benefit analyses. H4:The PDC intervention will be more effective
in improving psychosocial well-being and reducing health care service use for patients and
caregivers dealing with more severe patient impairment (e.g., cognitive status, functional
status, and level of problem behaviors). 2. To evaluate the impact of PDC on role and
intra-psychic strains caused by dementia and its care (patient and caregiver effects).
H5a:PDC, compared to usual care, will decrease patient role and intra-psychic strain,
including embarrassment about the illness, emotional strain, relationship strain, and social
isolation. H5b:PDC, compared to usual care, will decrease caregiver role and intra-psychic
strain, including role captivity, work care-related strain, relationship strain, emotional
and physical health deterioration, and caregiving efficacy. H6:The PDC intervention will be
more effective in decreasing role and intra-psychic strains for patients and caregivers
dealing with more severe patient impairment (e.g., cognitive status, functional status, and
level of problem behaviors). If effective, the long-term objective is to implement PDC in a
regional, QUERI-like demonstration (Quality Enhancement Research Initiative), involving
30-40 VA medical centers. Additionally, the PDC approach will be adapted for other chronic
conditions (e.g., heart disease, COPD, diabetes).
Methods: The proposed study is a 55-month, controlled trial of Partners in Dementia Care.
The PDC intervention will be implemented in two intervention sites and three comparison
sites that are matched on organizational, provider, and patient characteristics.
Findings: No findings at this time.
Background:
Dementia affects the entire family by negatively impacting multiple domains including
physical health, emotional health, social relationships, and legal and financial issues
(Gurland, 1980; Kunik, Snow, Molinari, Menke, Souchek, Sullivan et al, 2003; Schulz,
Visintainer, & Williamson, 1990; Wright, Clipp, & George, 1993). Particularly challenging is
accessing the range of services needed to address the care needs of both the individual with
dementia and the primary family caregiver. Common issues include: obtaining adequate
diagnostic testing; understanding treatment options and medications; difficulties with
memory and behavioral symptoms; and care- and illness-related strain (Mitnick, Leffler, &
Hood, 2010). Additionally, many unmet care needs are the result of service fragmentation and
inadequate communication among different medical providers, medical providers and consumers,
and medical providers and community services (Reuben, Levin, Frank, 2009).
Built upon two prior studies: the Cleveland Alzheimer's Managed Care Demonstration (Bass,
Clark, Looman, McCarthy, & Eckert, 2003) and the Chronic Care Networks for Alzheimer's
Disease (CCN/AD) (Maslow & Bass, 2003; Maslow & Selstad, 2001), PDC was a 5-year research
investigation that tested the effectiveness of a telephone-based, innovative
care-coordination intervention designed to address the unmet care needs of Veterans with
dementia and their family caregivers across all dementia stages. PDC was implemented through
formal partnerships between the VA medical centers and local Alzheimer's Association (AA)
chapters. Essential features of PDC included: 1) formal partnerships between VA medical
centers and Alzheimer's Association Chapters; 2) a multidimensional assessment and treatment
approach, 3) ongoing monitoring and long-term relationships with families; and 4) a
computerized information system to guide service delivery and fidelity monitoring. For a
complete description of the PDC intervention protocol please see Judge, Bass, Snow, Wilson,
Morgan, Looman, McCarthy, and Kunik (2010).
Objectives:
The primary objective of this investigation is to rigorously test the impact of PDC on a
number of outcomes for Veterans with dementia, family caregivers, and healthcare providers.
Within VA Medical Centers, the focus will be on improving dementia care in primary care
clinics, including geriatrics.
Two specific research objectives and corresponding hypotheses will be addressed:
1. To test the impact of PDC on three categories of outcomes: psychosocial well-being
outcomes (patient and caregiver effects); healthcare service use (patient effects
only); and health care cost (patient effects only).
Hypothesis 1: PDC, compared with usual care, will improve psychosocial well-being,
including depression, health status, adequacy of care, and quality of care for patients
with dementia and their caregivers.
Hypothesis 2: PDC, compared with usual care, will reduce healthcare service use for
patients with dementia, including hospital admissions, emergency department visits,
nursing home admissions, and physician visits.
Hypothesis 3: PDC is preferred to usual care, based on cost-effectiveness and
cost-benefit analyses.
Hypothesis 4: The PDC intervention will be more effective than usual care in improving
psychosocial well-being and reducing health care service use for patients and
caregivers dealing with more severe patient impairment (e.g., cognitive status,
functional status, and level of problem behaviors).
2. To evaluate the impact of PDC on role and intra-psychic strains caused by dementia and
its care (patient and caregiver effects).
Hypothesis 5a: PDC, compared with usual care, will decrease patient role and intra-psychic
strain, including embarrassment about the illness, emotional strain, relationship strain,
and social isolation.
Hypothesis 5b: PDC, compared with usual care, will decrease caregiver role and intra-psychic
strain, including role captivity, work care-related strain, relationship strain, emotional
and physical health deterioration, and caregiving efficacy.
Hypothesis 6: The PDC intervention will be more effective than usual care in decreasing role
and intra-psychic strains for patients and caregivers dealing with more severe patient
impairment (e.g., cognitive status, functional status, and level of problem behaviors).
If effective, the long-term objective is to implement PDC in a regional, Quality Enhancement
Research Initiative (QUERI)-like demonstration involving 30 to 40 VA medical centers.
Additionally, the PDC approach will be adapted for other chronic conditions (e.g., heart
disease, COPD, diabetes).
Methods:
The proposed study was a 55-month, controlled trial of PDC. The project was conducted at two
intervention sites and three comparison sites matched on organizational, provider, and
patient characteristics.
Partners in Dementia Care was compared to usual care. Both groups received educational
materials about dementia at the start.
PDC Intervention The Chronic Care Model (Bodenheimer, Wagner, & Grumbach, 2002; Bodenheimer,
Wagner, & Grumbach, 2002) was used as an overarching framework to implement PDC and included
the following components: 1) Formal linkages between medical centers (the VA) and community
agencies (the Alzheimer's Association); 2) Organizational support from key leaders and
broad-based training about PDC; 3) Delivery system redesign and decision support systems; 4)
Self-management of dementia as outlined by the PDC intervention protocol; 5) The development
of the PDC Care Coordination Information System (CCIS) as the clinical information system.
PDC had four primary ways of assisting families: 1) providing disease-related education and
information; 2) offering emotional support and coaching; 3) linking families to medical and
non-medical services and resources; and 4) mobilizing and organizing the informal care
network. Two key staff members implemented the intervention: a VA Dementia Care Coordinator
(VA DCC) in VA medical centers and an Alzheimer's Association Care Consultant (AA CC) in
Alzheimer's Association Chapters. VA DCCs primarily focused on veterans' medical and
non-medical needs and assisted families with effectively using VA resources; AA CCs
primarily focused on needs of informal caregivers such as care-related strain and accessing
non-VA resources. The intervention protocol consisted of: 1) Assessment of Care Needs across
medical and non-medical care issues that addressed 23 domains for Veterans and 14 domains
for caregivers; 2) Development of Care Goals that matched the priorities of Veterans and
caregivers; 3) Development of Action Steps which were concrete behavioral tasks intended to
help families move toward goal achievement (e.g., individual responsible for completing each
task, expected completion date); 4) On-going Monitoring of Action Steps on a regular basis
to ensure timely completion of tasks, address potential barriers, modify or add action
steps, and identify new goals.
Analytic Plan With one exception, measures of "objective" characteristics, including
community and support-service use, service knowledge, number of informal helpers, and
Veterans' impairments, were based on information reported by caregivers. The one exception
was a measure of impairment based on scores from a standardized mental status test that was
administered to Veterans over the telephone (i.e., the Blessed
Orientation-Memory-Concentration Test; Katzman et al., 1983). Additionally, a small number
of Veterans (approximately 5%) with mild dementia did not have a caregiver; "objective"
characteristics for these individuals were self-reported by the Veteran. Information used to
construct measures of "subjective" characteristics, such as feelings about or perceptions of
the quality of care and care-related strain, came directly from the individual whose
feelings or perceptions were being represente
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
| Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
| Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
| Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
| Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
| Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
| Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
| Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
| Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
| Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
| Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
| Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
| Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
| Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
| Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
| Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
| Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
| Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
| Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |